Bicyclic heterocycles as FGFR4 inhibitors
US9801889B2 · kind B2 · utility
36Cited by
32References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 17, 2017 |
| Grant date | Oct 31, 2017 |
| Priority date | — |
| Expiry date | Jan 17, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR4 enzyme and are useful in the treatment of FGFR4-associated diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.